The most frequently prescribed antibiotic classes in the United Statesincluding penicillins (amoxicillin, amoxicillin-clavulanate), cephalosporins (cephalexin, ceftriaxone), macrolides (azithromycin, clarithromycin), fluoroquinolones (ciprofloxacin, levofloxacin), and tetracyclines (doxycycline)have no documented pharmacological interactions with semaglutide
Most patients find the process quick and comfortable
Wegovy Pediatric Safety: What Parents Need to Know About Semaglutide for Children Under 12 Wegovy Pediatric (Under 12) Safety: Current Evidence and Clinical Guidance At a glance FDA-approved age range / Wegovy is approved for patients aged 12 years and older with obesity (BMI at or above the 95th percentile) Under-12 approval status / No FDA approval exists for semaglutide 2.4 mg in children below age 12 Key adolescent trial / STEP TEENS (N=201) demonstrated 16.1% mean BMI reduction at 68 weeks in adolescents aged 12 to 17 Pediatric trial gap / No completed RCT has enrolled children aged 6 to 11 for semaglutide 2.4 mg weight management GI adverse events / Nausea occurred in 42% of adolescent trial participants vs
We provide ongoing, regular monitoring to ensure safety and effectiveness, and we are always available to discuss concerns or adjust your treatment plan as your needs change
Contraindication: This product is contraindicated for use on persons under the age of 18 years
